{"transactions":[{"id":1999261,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-22T19:15:10.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":4235,"source":{"system":"sec-edgar","filing":"0001209191-23-011926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919123011926/doc4.xml","form_type":"4"}},{"id":2391529,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-16T20:01:45.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":32822,"source":{"system":"sec-edgar","filing":"0001209191-22-010377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919122010377/doc4.xml","form_type":"4"}},{"id":2812429,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-03T21:05:31.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a\nratio of 1-for-55."}],"balance_after":22822,"source":{"system":"sec-edgar","filing":"0001209191-21-017573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919121017573/doc4.xml","form_type":"4"}},{"id":3364040,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-20T19:27:37.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":225000,"price":0.1,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":704841,"source":{"system":"sec-edgar","filing":"0001209191-19-057497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119057497/doc4.xml","form_type":"4"}},{"id":3449024,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2019-08-02T20:41:08.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":1751,"price":0.403,"value":705.653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in\nconnection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":479841,"source":{"system":"sec-edgar","filing":"0001209191-19-044370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119044370/doc4.xml","form_type":"4"}},{"id":3622964,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-03-01T09:24:05.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":152415,"price":0.3798,"value":57887.217,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on the Current Report on Form 8-K filed on February 15, 2019, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on February 28, 2019, the reporting person received a total of 152,415 shares of common stock from the Company in lieu of $57,887 of cash compensation, which includes a portion of the reporting person's deferred annual bonus for 2018 that was payable on such date."}],"balance_after":481592,"source":{"system":"sec-edgar","filing":"0001209191-19-014816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119014816/doc4.xml","form_type":"4"}},{"id":3649403,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-02-19T08:54:06.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":22279,"price":0.3634,"value":8096.1886,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on the Current Report on Form 8-K filed on February 15, 2019, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on February 15, 2019, the reporting person received a total of 22,279 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":329177,"source":{"system":"sec-edgar","filing":"0001209191-19-010898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119010898/doc4.xml","form_type":"4"}},{"id":3677189,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-02-04T11:16:46.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":21470,"price":0.3771,"value":8096.337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on the Current Report on Form 8-K filed on September 4, 2018 and December 21, 2018, the reporting person has elected to receive\na portion of his compensation in stock in lieu of cash. Accordingly, on February 1, 2019, the reporting person received a total of 21,470 shares of\ncommon stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":306898,"source":{"system":"sec-edgar","filing":"0001209191-19-006663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119006663/doc4.xml","form_type":"4"}},{"id":3690554,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-01-22T10:25:37.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":23729,"price":0.3412,"value":8096.3348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on the Current Report on Form 8-K filed on September 4, 2018 and December 21, 2018, the reporting person has elected to receive\na portion of his compensation in stock in lieu of cash. Accordingly, on January 18, 2019, the reporting person received a total of 23,729 shares of\ncommon stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":285428,"source":{"system":"sec-edgar","filing":"0001209191-19-004688","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119004688/doc4.xml","form_type":"4"}},{"id":3701761,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-01-07T09:14:43.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":23139,"price":0.3499,"value":8096.3361,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on the Current Report on Form 8-K filed on September 4, 2018 and December 21, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on January 4, 2019, the reporting person received a total of 23,139 shares of common\nstock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":261699,"source":{"system":"sec-edgar","filing":"0001209191-19-002394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919119002394/doc4.xml","form_type":"4"}},{"id":3718959,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-12-26T09:20:50.000Z","date":"2018-12-21","kind":"grant","acquired":true,"shares":27445,"price":0.295,"value":8096.275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on December 21, 2018, the reporting person received a total of 27,445 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":238560,"source":{"system":"sec-edgar","filing":"0001209191-18-064049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118064049/doc4.xml","form_type":"4"}},{"id":3737417,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-12-10T09:34:03.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":21882,"price":0.37,"value":8096.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on December 7, 2018, the reporting person received a total of 21,882 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":211115,"source":{"system":"sec-edgar","filing":"0001209191-18-061677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118061677/doc4.xml","form_type":"4"}},{"id":3752792,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-11-26T09:29:35.000Z","date":"2018-11-23","kind":"grant","acquired":true,"shares":25941,"price":0.3121,"value":8096.1861,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his\ncompensation in stock in lieu of cash. Accordingly, on November 23, 2018, the reporting person received a total of 25,941 shares of common\nstock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":189233,"source":{"system":"sec-edgar","filing":"0001209191-18-059875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118059875/doc4.xml","form_type":"4"}},{"id":3766610,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-11-13T09:24:59.000Z","date":"2018-11-09","kind":"grant","acquired":true,"shares":18698,"price":0.433,"value":8096.234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on November 9, 2018, the reporting person received a total of 18,698 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":163292,"source":{"system":"sec-edgar","filing":"0001209191-18-058091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118058091/doc4.xml","form_type":"4"}},{"id":3781160,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-10-29T09:26:35.000Z","date":"2018-10-26","kind":"grant","acquired":true,"shares":18519,"price":0.4372,"value":8096.5068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his\ncompensation in stock in lieu of cash. Accordingly, on October 26, 2018, the reporting person received a total of 18,519 shares of common stock\nfrom the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":144594,"source":{"system":"sec-edgar","filing":"0001209191-18-056341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118056341/doc4.xml","form_type":"4"}},{"id":3790571,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-10-15T09:24:08.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":17230,"price":0.4699,"value":8096.377,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on October 12, 2018, the reporting person received a total of 17,230 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date."}],"balance_after":126075,"source":{"system":"sec-edgar","filing":"0001209191-18-054919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118054919/doc4.xml","form_type":"4"}},{"id":3804204,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2018-10-01T12:40:37.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":73587,"price":1.17,"value":86096.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As reported on a Current Report on Form 8-K filed on September 4, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on September 28, 2018, the reporting person received a total of 73,587 shares of common stock from the Company in lieu of $86,096.16 of cash compensation that was payable on such date, which includes base salary and a portion of the reporting person's deferred annual bonus for 2017, which was paid on September 28, 2018."}],"balance_after":108845,"source":{"system":"sec-edgar","filing":"0001209191-18-052657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118052657/doc4.xml","form_type":"4"}},{"id":3853000,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2018-08-03T21:29:49.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in four equal annual installments."}],"balance_after":21000,"derivative":{"exercise_price":1.79,"expiration_date":"2028-08-01","underlying":"Common stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001209191-18-045456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118045456/doc4.xml","form_type":"4"}},{"id":3852999,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-08-03T21:29:49.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":35258,"source":{"system":"sec-edgar","filing":"0001209191-18-045456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919118045456/doc4.xml","form_type":"4"}},{"id":4197552,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-10-02T15:44:43.000Z","date":"2017-10-02","kind":"purchase","acquired":true,"shares":7100,"price":0.45,"value":3195.0,"ownership":{"direct":true},"balance_after":142583,"source":{"system":"sec-edgar","filing":"0001209191-17-054555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117054555/doc4.xml","form_type":"4"}},{"id":4197551,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-10-02T15:44:43.000Z","date":"2017-10-02","kind":"purchase","acquired":true,"shares":200,"price":0.46,"value":92.0,"ownership":{"direct":true},"balance_after":135483,"source":{"system":"sec-edgar","filing":"0001209191-17-054555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117054555/doc4.xml","form_type":"4"}},{"id":4197550,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-10-02T15:44:43.000Z","date":"2017-10-02","kind":"purchase","acquired":true,"shares":2700,"price":0.44,"value":1188.0,"ownership":{"direct":true},"balance_after":135283,"source":{"system":"sec-edgar","filing":"0001209191-17-054555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117054555/doc4.xml","form_type":"4"}},{"id":4225409,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-08-24T11:55:20.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":739,"price":0.56,"value":413.84,"ownership":{"direct":true},"balance_after":132583,"source":{"system":"sec-edgar","filing":"0001209191-17-050044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117050044/doc4.xml","form_type":"4"}},{"id":4225408,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-08-24T11:55:20.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":4361,"price":0.55,"value":2398.55,"ownership":{"direct":true},"balance_after":131844,"source":{"system":"sec-edgar","filing":"0001209191-17-050044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117050044/doc4.xml","form_type":"4"}},{"id":4225407,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-08-24T11:55:20.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":4900,"price":0.545,"value":2670.5,"ownership":{"direct":true},"balance_after":127483,"source":{"system":"sec-edgar","filing":"0001209191-17-050044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117050044/doc4.xml","form_type":"4"}},{"id":4274431,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-06-22T11:49:07.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":5000,"price":0.62,"value":3100.0,"ownership":{"direct":true},"balance_after":122583,"source":{"system":"sec-edgar","filing":"0001209191-17-041289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117041289/doc4.xml","form_type":"4"}},{"id":4274430,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-06-22T11:49:07.000Z","date":"2017-06-22","kind":"purchase","acquired":true,"shares":5000,"price":0.63,"value":3150.0,"ownership":{"direct":true},"balance_after":117583,"source":{"system":"sec-edgar","filing":"0001209191-17-041289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117041289/doc4.xml","form_type":"4"}},{"id":4344511,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-04-26T10:52:39.000Z","date":"2017-04-26","kind":"purchase","acquired":true,"shares":10000,"price":0.648,"value":6480.0,"ownership":{"direct":true},"balance_after":112583,"source":{"system":"sec-edgar","filing":"0001209191-17-028187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117028187/doc4.xml","form_type":"4"}},{"id":4377644,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-03-20T09:16:41.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":15,"price":0.7655,"value":11.4825,"ownership":{"direct":true},"balance_after":102583,"source":{"system":"sec-edgar","filing":"0001209191-17-021599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117021599/doc4.xml","form_type":"4"}},{"id":4377643,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-03-20T09:16:41.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":665,"price":0.7651,"value":508.7915,"ownership":{"direct":true},"balance_after":102568,"source":{"system":"sec-edgar","filing":"0001209191-17-021599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117021599/doc4.xml","form_type":"4"}},{"id":4377642,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-03-20T09:16:41.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":9320,"price":0.7695,"value":7171.74,"ownership":{"direct":true},"balance_after":101903,"source":{"system":"sec-edgar","filing":"0001209191-17-021599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117021599/doc4.xml","form_type":"4"}},{"id":4435728,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-02-21T07:11:24.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":2917,"price":0.695,"value":2027.315,"ownership":{"direct":true},"balance_after":92583,"source":{"system":"sec-edgar","filing":"0001209191-17-012427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117012427/doc4.xml","form_type":"4"}},{"id":4435727,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-02-21T07:11:24.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":6883,"price":0.6924,"value":4765.7892,"ownership":{"direct":true},"balance_after":89666,"source":{"system":"sec-edgar","filing":"0001209191-17-012427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117012427/doc4.xml","form_type":"4"}},{"id":4435726,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-02-21T07:11:24.000Z","date":"2017-02-17","kind":"purchase","acquired":true,"shares":200,"price":0.6915,"value":138.3,"ownership":{"direct":true},"balance_after":82783,"source":{"system":"sec-edgar","filing":"0001209191-17-012427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117012427/doc4.xml","form_type":"4"}},{"id":4461375,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-02-08T11:43:08.000Z","date":"2017-02-08","kind":"purchase","acquired":true,"shares":10000,"price":0.685,"value":6850.0,"ownership":{"direct":true},"balance_after":82583,"source":{"system":"sec-edgar","filing":"0001209191-17-008542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117008542/doc4.xml","form_type":"4"}},{"id":4468271,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2017-02-03T17:14:30.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in a one-quarter installment on the one year anniversary of the grant date and in monthly installments thereafter over the\nremaining three years."}],"balance_after":13000,"derivative":{"exercise_price":0.629,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-17-007720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117007720/doc4.xml","form_type":"4"}},{"id":4480484,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-26T08:05:56.000Z","date":"2017-01-25","kind":"purchase","acquired":true,"shares":9700,"price":0.6968,"value":6758.96,"ownership":{"direct":true},"balance_after":72583,"source":{"system":"sec-edgar","filing":"0001209191-17-005642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117005642/doc4.xml","form_type":"4"}},{"id":4480483,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-26T08:05:56.000Z","date":"2017-01-25","kind":"purchase","acquired":true,"shares":300,"price":0.69,"value":207.0,"ownership":{"direct":true},"balance_after":62883,"source":{"system":"sec-edgar","filing":"0001209191-17-005642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117005642/doc4.xml","form_type":"4"}},{"id":4486385,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-19T13:48:47.000Z","date":"2017-01-19","kind":"purchase","acquired":true,"shares":600,"price":0.6949,"value":416.94,"ownership":{"direct":true},"balance_after":62583,"source":{"system":"sec-edgar","filing":"0001209191-17-004383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117004383/doc4.xml","form_type":"4"}},{"id":4486384,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-19T13:48:47.000Z","date":"2017-01-19","kind":"purchase","acquired":true,"shares":3000,"price":0.6946,"value":2083.8,"ownership":{"direct":true},"balance_after":61983,"source":{"system":"sec-edgar","filing":"0001209191-17-004383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117004383/doc4.xml","form_type":"4"}},{"id":4486383,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-19T13:48:47.000Z","date":"2017-01-19","kind":"purchase","acquired":true,"shares":6400,"price":0.695,"value":4448.0,"ownership":{"direct":true},"balance_after":58983,"source":{"system":"sec-edgar","filing":"0001209191-17-004383","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117004383/doc4.xml","form_type":"4"}},{"id":4507435,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-01-03T06:39:58.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":2000,"price":0.726,"value":1452.0,"ownership":{"direct":true},"balance_after":52583,"source":{"system":"sec-edgar","filing":"0001209191-17-000003","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919117000003/doc4.xml","form_type":"4"}},{"id":4511781,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2016-12-27T06:43:24.000Z","date":"2016-12-23","kind":"grant","acquired":true,"shares":3000,"price":0.719,"value":2157.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":4500,"source":{"system":"sec-edgar","filing":"0001209191-16-156732","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919116156732/doc4.xml","form_type":"4"}},{"id":4512374,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2016-12-23T06:12:25.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":3000,"price":0.749,"value":2247.0,"ownership":{"direct":true},"balance_after":53583,"source":{"system":"sec-edgar","filing":"0001209191-16-156612","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919116156612/doc4.xml","form_type":"4"}},{"id":4515226,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock warrant","published_at":"2016-12-20T21:33:28.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33333,"derivative":{"exercise_price":0.9,"exercise_date":"2016-12-21","expiration_date":"2021-12-21","underlying":"Common stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001209191-16-156238","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919116156238/doc4.xml","form_type":"4"}},{"id":4515225,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":116605,"kind":"person","name":"CAUWENBERGH GEERT","position":1,"cik":"0001285648","reported_name":"CAUWENBERGH GEERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common stock, $0.0001 par value","published_at":"2016-12-20T21:33:28.000Z","date":"2016-12-16","kind":"grant","acquired":true,"shares":33333,"price":0.9,"value":29999.7,"ownership":{"direct":true},"balance_after":50583,"source":{"system":"sec-edgar","filing":"0001209191-16-156238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285648/000120919116156238/doc4.xml","form_type":"4"}}]}